HIV/AIDS Therapy
Virological response, not mortality improved in first decade of HAART use in HIV/AIDS
Published in TB and Outbreaks Week, October 3rd, 2006
"Highly active antiretroviral therapy (HAART) for the treatment of HIV infection was introduced a decade ago. We aimed to examine trends in the characteristics of patients starting HAART in Europe and North America, and their treatment response and short-term prognosis," scientists in England report.
According to M.T. May and colleagues at the University of Bristol, "We analyzed data from 22,217 treatment-naive HIV-1-infected adults who had started HAART and were followed up in one of 12 cohort studies.
"The probability...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Nosocomial Infections
Multiple Acinetobacter outbreak strains in Netherlands from 1999-2001 genotyped - SARS Outbreaks
SARS outbreak in a general hospital in Tianjin linked to single super-spreader - Streptococcus Suis Outbreaks
Streptococcus suis outbreak caused by highly virulent sequence type 7 strain - Avian Influenza
"Duty of care" among healthcare workers must be redefined in anticipation of an avian flu pandemic - Avian Influenza
Live H5N1 bird flu virus vaccines show protection in animal studies - Blood Safety
Precautions necessary during hand surgery on patients at high-risk for blood-borne viruses - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
